Additional File 1: of Comprehensive Characterization of Circular RNAs in ~â1000 Human Cancer Cell Lines

Hang Ruan,Xiang Yu,Junsuk Ko,Shengli Li,Ying Jing,Xiaoyu Zhu,Youqiong Ye,Zhao Zhang,Tingting Mills,Jing Feng,Chun‐Jen Liu,Jing Ji,Jin Cao,Bingying Zhou,Li Wang,Yubin Zhou,Chunru Lin,An‐Yuan Guo,Xi Chen,Lixia Diao,Wenbo Li,Zhiao Chen,Xiong He,Gordon B. Mills,Michael L. Blackburn,Leng Han
DOI: https://doi.org/10.6084/m9.figshare.9730346.v1
2019-01-01
Abstract:Figure S1. Expression landscape of circRNAs across cancer cell lines. Figure S2. Potential regulation of EMT on biogenesis of circRNAs. Figure S3. Enrichment of circRNAs in clinically actionable genes. Figure S4. Characterization of functional effects and drug response of circMYC in cancer. Figure S5. Therapeutic liability of circRNAs in CTRP. Figure S6. Examples of modules in CircRiC. Table S1. Summary of circRNAs identified across different cancer cell lines. (PDF 7931 kb)
What problem does this paper attempt to address?